Tonix Pharmaceuticals Holding Corp (TNXP)
0.1835
+0.01
(+7.25%)
USD |
NASDAQ |
May 03, 16:00
0.1723
-0.01
(-6.10%)
After-Hours: 20:00
Tonix Pharmaceuticals Revenue (Quarterly): 3.779M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.779M |
Date | Value |
---|---|
September 30, 2023 | 3.989M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.779M
Minimum
Dec 2023
3.989M
Maximum
Sep 2023
3.884M
Average
3.884M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -27.32M |
Total Expenses (Quarterly) | 31.11M |
EPS Diluted (Quarterly) | -0.4661 |
Enterprise Value | 1.495M |
Gross Profit Margin (Quarterly) | 37.36% |
Profit Margin (Quarterly) | -723.0% |
Earnings Yield | -4.48K% |